Literature DB >> 10367555

Relationships of plasma tryptophan availability to course of illness and clinical features of alcoholism: a preliminary study.

A C Swann1, B A Johnson, C R Cloninger, Y R Chen.   

Abstract

RATIONALE: Serotonergic (5-HT) mechanisms may be involved in impulse control (including antisocial behavior) across psychiatric syndromes. Age of onset may differentiate alcoholics on psychopathological characteristics associated with impulse control, especially mood disturbance, hostility, and a broad range of antisocial behaviors. Thus, there may be a predictable relationship between markers of 5-HT function and age of onset-related characteristics.
OBJECTIVE: We tested the hypothesis that there would be a predictable relationship between the ratio of plasma tryptophan to large neutral amino acids (i.e. TRYP/LNAA ratio), a marker of 5-HT function, age of onset and related psychopathological characteristics associated with impulse control.
METHODS: Fifty-eight male and female DSM-IV diagnosed alcoholics attending an outpatient treatment center completing a comprehensive psychopathological assessment, and from whom blood samples were obtained.
RESULTS: Plasma TRYP/LNAA ratio was positively correlated with symptoms of dysphoria, and negatively associated with harm avoidance on Cloninger's Temperament and Character Inventory. Low tryptophan availability was associated with antisocial-type personality characteristics. Interestingly, the few (nine) subjects who had both early onset alcoholism and antisocial personality disorder had a higher plasma tryptophan but similar TRYP/LNAA ratio to the others.
CONCLUSIONS: These data suggest that a low plasma TRYP/LNAA ratio is associated with susceptibility to anxiety, antisocial-type personality characteristics, and an early age of onset for alcoholism. In contrast, a high plasma TRYP/LNAA ratio is associated with a later onset of alcoholism and dysphoria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367555     DOI: 10.1007/s002130050962

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.

Authors:  Henry R Kranzler; Stephen Armeli; Howard Tennen; Jonathan Covault; Richard Feinn; Albert J Arias; Helen Pettinati; Cheryl Oncken
Journal:  J Clin Psychopharmacol       Date:  2011-02       Impact factor: 3.153

2.  Comparison of alcoholism subtypes as moderators of the response to sertraline treatment.

Authors:  Henry R Kranzler; Richard Feinn; Stephen Armeli; Howard Tennen
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

3.  Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism.

Authors:  John D Roache; Yanmei Wang; Nassima Ait-Daoud; Bankole A Johnson
Journal:  Alcohol Clin Exp Res       Date:  2008-06-28       Impact factor: 3.455

4.  Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter.

Authors:  Michael A Dawes; John D Roache; Martin A Javors; Susan E Bergeson; Dawn M Richard; Charles W Mathias; Nassima Ait-Daoud; Donald M Dougherty; Bankole A Johnson
Journal:  J Stud Alcohol Drugs       Date:  2009-11       Impact factor: 2.582

Review 5.  Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.

Authors:  Young-Chul Jung; Kee Namkoong
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

6.  The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse.

Authors:  Dubravka Svob Strac; Gordana Nedic Erjavec; Matea Nikolac Perkovic; Korona Nenadic-Sviglin; Marcela Konjevod; Mirko Grubor; Nela Pivac
Journal:  Neuropsychiatr Dis Treat       Date:  2019-01-24       Impact factor: 2.570

Review 7.  Medications to treat alcoholism.

Authors:  B A Johnson; N Ait-Daoud
Journal:  Alcohol Res Health       Date:  1999
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.